Our results with combined G-CSF administration and Bcl-xL blockade suggest a qualitative change of the tumor-infiltrating neutrophil pool, whereby old, tumor-supportive TANs are replaced by younger, possibly tumor-antagonizing neutrophils. This evidence concerns the gene CSF3 and neoplasm.